Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for September 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Hospital Admissions Not Related to COVID-19 Fell in Early 2020
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Non-COVID-19 hospital admissions decreased considerably with the onset of COVID-19, with declines generally similar across patient demographic subgroups from February to April 2020, according to a report published online Sept. 24 in Health Affairs.
Proton Pump Inhibitor Use Linked to Increased T2DM Risk
TUESDAY, Sept. 29, 2020 (HealthDay News) — Regular use of proton pump inhibitors (PPIs) is associated with an increased risk for type 2 diabetes, according to a study published online Sept. 28 in Gut.
Private Health Plans Pay Hospitals 247 Percent of Medicare
MONDAY, Sept. 28, 2020 (HealthDay News) — During 2018, prices paid to hospitals by privately insured patients averaged 247 percent of what Medicare would have paid, according to a study from the RAND Corporation.
Exposure to Maternal Gestational Diabetes Tied to Higher CVD Risk
MONDAY, Sept. 28, 2020 (HealthDay News) — Intrauterine exposure to maternal gestational diabetes is associated with an increased cardiovascular disease risk and risk factors in offspring up to age 35 years, according to a study published online Sept. 28 in CMAJ, the journal of the Canadian Medical Association.
Major Adverse CV Event Risk Reduced With SGLT2 Inhibitors
THURSDAY, Sept. 24, 2020 (HealthDay News) — For individuals with type 2 diabetes, sodium glucose cotransporter 2 (SGLT2) inhibitors are associated with a reduced risk for cardiovascular events during short-term follow-up, according to a study published online Sept. 23 in The BMJ.
Measures of Central Adiposity Linked to All-Cause Mortality
THURSDAY, Sept. 24, 2020 (HealthDay News) — Several indices of central adiposity, including waist circumference and body adiposity index, are associated with an increased risk for all-cause mortality, according to a review published online Sept. 23 in The BMJ.
Heavy Sugar-Sweetened Drink Intake Decreasing Overall in U.S.
THURSDAY, Sept. 24, 2020 (HealthDay News) — Overall, heavy sugar-sweetened beverage (SSB) intake is declining among adults and children, according to a study published online Sept. 24 in the Journal of the Academy of Nutrition and Dietetics.
Abstract/Full Text (subscription or payment may be required)
Metformin May Slow Cognitive Decline in Seniors With T2DM
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — For older adults with type 2 diabetes, cognitive decline is slower and dementia risk reduced for those receiving metformin, according to a study published online Sept. 23 in Diabetes Care.
Weaker Handgrip Strength Tied to Higher Likelihood of Diabetes 
Burden of Diabetes, Untreated Diabetes Increased From 1990 to 2022 
In-Utero Sugar Restriction Cuts Offspring"s Risk for Diabetes, Hypertension 
Prevalence of Diabetes 15.8 Percent in U.S. Adults From 2021 to 2023 
AI Can Help ID Patients With Diabetes at Highest Risk for Cardiomyopathy 
Comorbid Diabetes Increases Risk for Lower Extremity Amputation With Kidney Disease 
Metabolic Risk Contributes to Diabetes Onset in People With HIV 
